WEBSITE BSE:543997 NSE : ORGANICREC 17 May, 09:37
Market Cap ₹176 Cr.
Stock P/E 0.0
P/B 2.3
Current Price ₹228.2
Book Value ₹ 97.9
Face Value 10
52W High ₹310
Dividend Yield 0%
52W Low ₹ 208.6
ORS was established in 2008 and has a track record of successfully operating one of India’s pioneering waste-to-energy plants, based on anaerobic biomethanation technology. ORS’s business verticals include the Build Own Operate Transfer (BOOT) model, the Engineering Procurement and Commissioning (EPC) model and the Supply of Key Equipment. ORS provides services such as EPC services in waste management, commissioning services, consulting and advisory services in the waste management sector, planning, building, and managing waste management projects, laboratory services and more. ORS also has a patented DRY ANAEROBIC DIGESTION (DRYAD) technology which is capable of treating several kinds of waste and converting them into electricity and compost. ORS has a team of experienced promoters and management personnel who have more than 14 years of extensive experience in the waste management sector.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|---|---|
| Net Sales | 5 | 8 | 11 | 13 | 15 | 25 | |
| Other Income | 0 | 1 | 0 | 3 | 3 | 1 | |
| Total Income | 5 | 9 | 11 | 16 | 18 | 25 | |
| Total Expenditure | 14 | 18 | 21 | 12 | 15 | 13 | |
| Operating Profit | -9 | -9 | -10 | 3 | 2 | 12 | |
| Interest | 2 | 3 | 3 | 1 | 2 | 2 | |
| Depreciation | 4 | 5 | 7 | 6 | 6 | 5 | |
| Exceptional Income / Expenses | 0 | 0 | -3 | 0 | 0 | 0 | |
| Profit Before Tax | -16 | -17 | -23 | -4 | -5 | 5 | |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 1 | |
| Profit After Tax | -16 | -17 | -23 | -4 | -5 | 4 | |
| Adjustments | 0 | 0 | 0 | -0 | -0 | 0 | |
| Profit After Adjustments | -16 | -17 | -23 | -4 | -5 | 4 | |
| Adjusted Earnings Per Share | -38.7 | -41.9 | -54.2 | -10.8 | -12.9 | 7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 67% | 31% | 38% | 0% |
| Operating Profit CAGR | 500% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 22% | -20% | -36% | -36% |
| ROCE Average | 9% | -0% | -8% | -9% |
| #(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
| Shareholder's Funds | 46 | 40 | 18 | 13 | 8 | 26 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 7 | 6 | 41 | 47 | 47 | 67 |
| Other Non-Current Liabilities | 15 | 15 | 3 | 5 | -3 | -2 |
| Total Current Liabilities | 54 | 62 | 31 | 30 | 47 | 22 |
| Total Liabilities | 122 | 123 | 94 | 95 | 99 | 112 |
| Fixed Assets | 47 | 81 | 75 | 69 | 65 | 60 |
| Other Non-Current Assets | 62 | 27 | 5 | 8 | 11 | 14 |
| Total Current Assets | 12 | 15 | 14 | 19 | 24 | 38 |
| Total Assets | 122 | 123 | 94 | 95 | 99 | 112 |
| #(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 1 | 0 |
| Cash Flow from Operating Activities | -8 | -14 | -4 | -0 | 8 | -24 |
| Cash Flow from Investing Activities | -6 | -40 | 1 | -4 | -7 | -4 |
| Cash Flow from Financing Activities | 14 | 54 | 3 | 4 | -2 | 28 |
| Net Cash Inflow / Outflow | 0 | 0 | -0 | 1 | -1 | -0 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 1 | 0 | 0 |
| # | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -38.72 | -41.89 | -54.19 | -10.82 | -12.88 | 7.03 |
| CEPS(Rs) | -27.86 | -29.93 | 0 | 4.71 | 1.48 | 16.56 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 109.09 | 96.65 | 42.1 | 31.28 | 18.4 | 48.75 |
| Core EBITDA Margin(%) | -192.84 | -121.11 | -92.31 | 1.48 | -4.56 | 45.51 |
| EBIT Margin(%) | -280.67 | -172.25 | -175.99 | -23.99 | -25.14 | 27.97 |
| Pre Tax Margin(%) | -327.43 | -208.49 | -201.89 | -35.87 | -36.59 | 18.84 |
| PAT Margin (%) | -327.43 | -208.49 | -201.89 | -35.87 | -36.59 | 14.78 |
| Cash Profit Margin (%) | -235.62 | -148.98 | -139.75 | 15.61 | 4.2 | 34.84 |
| ROA(%) | -13.13 | -14.15 | -20.76 | -4.75 | -5.5 | 3.46 |
| ROE(%) | -35.49 | -40.72 | -78.32 | -29.47 | -51.81 | 22.15 |
| ROCE(%) | -14.89 | -15.63 | -24.88 | -4.46 | -5.64 | 8.77 |
| Receivable days | 132.39 | 163.21 | 251.71 | 353.21 | 430.99 | 378.55 |
| Inventory Days | 210.93 | 116.43 | 60.25 | 33.11 | 28.36 | 15.51 |
| Payable days | 0 | 231.11 | 324.97 | 938.85 | 2069.24 | 3551.67 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 8.83 | 5.71 | 4.39 | 4.31 | 3.72 | 3.03 |
| EV/Core EBITDA(x) | -4.67 | -5.06 | -4.86 | 15.7 | 23.78 | 6.31 |
| Net Sales Growth(%) | 0 | 69.91 | 34.09 | 12.32 | 16.69 | 69.15 |
| EBIT Growth(%) | 0 | -4.28 | -37 | 84.69 | -22.28 | 288.21 |
| PAT Growth(%) | 0 | -8.19 | -29.84 | 80.04 | -19.02 | 168.34 |
| EPS Growth(%) | 0 | -8.19 | -29.37 | 80.04 | -19.06 | 154.56 |
| Debt/Equity(x) | 1.02 | 1.25 | 2.72 | 4.06 | 6.7 | 2.74 |
| Current Ratio(x) | 0.23 | 0.25 | 0.44 | 0.63 | 0.5 | 1.76 |
| Quick Ratio(x) | 0.18 | 0.21 | 0.4 | 0.59 | 0.48 | 1.72 |
| Interest Cover(x) | -6 | -4.75 | -6.8 | -2.02 | -2.2 | 3.06 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Sep 2023 | Mar 2024 |
|---|---|---|
| Promoter | 20.35 | 20.35 |
| FII | 0 | 0 |
| DII | 1.69 | 0 |
| Public | 77.96 | 79.65 |
| Others | 0 | 0 |
| Total | 100 | 100 |
| # | Sep 2023 | Mar 2024 |
|---|---|---|
| Promoter | 0.16 | 0.16 |
| FII | 0 | 0 |
| DII | 0.01 | 0 |
| Public | 0.6 | 0.61 |
| Others | 0 | 0 |
| Total | 0.77 | 0.77 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
